LWAY
$25.82
+$1.12 (4.53%)+4.53%
ClosedLoading chart...
IndexN/A
Market Cap0.39B
Enterprise Value0.36B
Income$0.00B
Sales$0.05B
EmployeesN/A
P/E26.62
P/S1.73
P/B4.29
P/C-22.44
EV/EBITDA15.30
EV/SalesN/A
EPS (ttm)0.97
EarningsN/A
Gross Margin27.39%
Oper. Margin7.61%
Profit Margin6.52%
Volume0.43M
Shs Outstand0.02B
Change4.53%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $186.82M | $160.12M | $141.57M | $119.06M | $102.03M | $93.66M | $103.35M | $118.89M |
| Cost of Revenue | $138.25M | $117.68M | $114.78M | $90.36M | $75.09M | $71.51M | $77.49M | $88.20M |
| Gross Profit | $48.57M | $42.44M | $26.79M | $28.71M | $26.93M | $22.15M | $25.86M | $30.70M |
| Gross Margin | 26.00% | 26.51% | 18.92% | 24.11% | 26.40% | 23.65% | 25.02% | 25.82% |
| Operating Expenses | $34.72M | $25.45M | $24.44M | $22.83M | $22.01M | $24.08M | $28.97M | $31.22M |
| Operating Income | $13.85M | $17.00M | $2.35M | $5.88M | $4.92M | $-1.93M | $-3.11M | $-526.00K |
| Operating Margin | 7.41% | 10.61% | 1.66% | 4.94% | 4.83% | -2.06% | -3.01% | -0.44% |
| Net Income | $9.03M | $11.37M | $924.00K | $3.31M | $3.23M | $453.00K | $-3.09M | $-346.00K |
| Net Margin | 4.83% | 7.10% | 0.65% | 2.78% | 3.17% | 0.48% | -2.99% | -0.29% |
| EPS (Basic) | $0.61 | $0.78 | $0.06 | $0.21 | $0.21 | $0.03 | $-0.19 | $-0.02 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $90.55M | $82.64M | $69.00M | $71.55M | $62.05M | $58.55M | $56.81M | $64.52M |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $18.64M | $22.20M | $21.43M | $22.42M | $15.20M | $15.29M | $14.40M | $17.93M |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $71.91M | $60.44M | $47.57M | $49.13M | $46.85M | $43.25M | $42.41M | $46.59M |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $71.91M | $60.44M | $47.57M | $49.13M | $46.85M | $43.25M | $42.41M | $46.59M |
| Total Liabilities & Stockholders Equity | $90.55M | $82.64M | $69.00M | $71.55M | $62.05M | $58.55M | $56.81M | $64.52M |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Tangible Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $9.03M | $11.37M | $924.00K | $3.31M | $3.23M | $453.00K | $-3.09M | $-346.00K |
| Depreciation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $12.96M | $16.94M | $3.99M | $5.56M | $6.38M | $3.81M | $2.42M | $3.81M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
EDWARD SMOLYANSKY, KEY LWAY SHAREHOLDER: TERMINATION OF POISON PILL MARKS IMPORTANT INFLECTION POINT FOR LIFEWAY SHAREHOLDERS AS GOVERNANCE QUESTIONS MOUNT AHEAD OF THE ELECTIONBenzinga The Law Offices of Frank R. Cruz Announces Investigation of Lifeway Foods, Inc. (LWAY) on Behalf of InvestorsGlobeNewswire Inc. The Law Offices of Frank R. Cruz Announces Investigation of Lifeway Foods, Inc. (LWAY) on Behalf of InvestorsBenzinga Insider Transaction: Edward Smolyansky Sells $435K Worth Of Lifeway Foods SharesBenzinga Edward and Ludmila Smolyansky Call for Lifeway Foods (NASDAQ: LWAY) to Establish a Special Committee to Evaluate Danone's OfferBenzinga Edward and Ludmila Smolyansky Support Danone Bid to Acquire Lifeway Foods (NASDAQ: LWAY)Benzinga Lifeway Foods (LWAY) Q1 Earnings Miss, Sales Beat EstimatesZacks Investment Research Is Lifeway Foods (LWAY) Stock Outpacing Its Consumer Staples Peers This Year?Zacks Investment Research
Show 12 more stories
Lifeway Foods (LWAY) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research Lifeway Foods (LWAY) Readies for Q1 Earnings: What to Expect?Zacks Investment Research Zacks.com featured highlights include Valero, Group 1 Automotive, Lifeway Foods, EMCOR and Sprouts FarmersZacks Investment Research Bet on Winning DuPont Analysis & Pick 5 Quality StocksZacks Investment Research 5 Consumer Staples Stocks to Buy as Inflation Remains HighZacks Investment Research Is KimberlyClark (KMB) Outperforming Other Consumer Staples Stocks This Year?Zacks Investment Research Lifeway Foods (LWAY) Ascends While Market Falls: Some Facts to NoteZacks Investment Research Why the Market Dipped But Lifeway Foods (LWAY) Gained TodayZacks Investment Research The Zacks Analyst Blog Highlights Abercrombie & Fitch, Core & Main, EMCOR, Lifeway Foods and CompoSecureZacks Investment Research Lifeway Foods (LWAY) Rises Higher Than Market: Key FactsZacks Investment Research 5 Stocks to Buy as Curtains Just About Drop on Tax SeasonZacks Investment Research Are Consumer Staples Stocks Lagging Lifeway Foods (LWAY) This Year?Zacks Investment Research
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Company
About the company
Lifeway Foods, Inc. manufactures and distributes a variety of probiotic-rich goods, serving both the United States and international markets. Its principal offering is drinkable kefir, a fermented dairy item available in numerous forms, including organic and conventional options, various volumes, flavors, and formulations such as reduced-fat, fat-free, whole milk, high-protein, and BioKefir. Additionally, the company supplies European-style soft cheeses, cream, and other dairy selections. Their product portfolio also features ProBugs, a dedicated kefir line for children; single-serving cupped kefirs; Icelandic Skyr, which includes strained kefir and yogurt products; and frozen kefir in both soft-serve and pre-packaged pint formats. These products are sold under their proprietary Lifeway and Fresh Made brand names, and also as private label merchandise for other customers. Sales are primarily conducted via their internal sales personnel, alongside the use of brokers and third-party distributors. The company was founded in 1986 and maintains its headquarters in Morton Grove, Illinois.
Discover more
You may be interested in